@Article{Szmyrka-Kaczmarek2009,
journal="Reumatologia/Rheumatology",
issn="0034-6233",
volume="47",
number="2",
year="2009",
title="Tocilizumab \– interleukin 6 receptor inhibitor \– a new therapeutic option in the treatment of rheumatoid arthritis",
abstract="Interleukin 6 is a pleiotropic cytokine which regulates the innate and adaptive immune response, inflammation and acute phase response. It plays a significant role in various chronic inflammatory processes including rheumatoid arthritis. The inhibition of IL-6 signal transduction by monoclonal antibodies against IL-6 receptor is a new efficient and safe therapeutic method in rheumatoid arthritis",
author="Szmyrka-Kaczmarek, Magdalena
and Wiland, Piotr",
pages="85--94",
url="https://www.termedia.pl/Tocilizumab-8211-interleukin-6-receptor-inhibitor-8211-a-new-therapeutic-option-in-the-treatment-of-rheumatoid-arthritis,18,12567,1,1.html"
}